metronidazole has been researched along with rifampin in 95 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (25.26) | 18.7374 |
1990's | 7 (7.37) | 18.2507 |
2000's | 26 (27.37) | 29.6817 |
2010's | 28 (29.47) | 24.3611 |
2020's | 10 (10.53) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bohlin, L; Charnock, C; Gundersen, LL; Hedner, E; Larsson, R; Samuelsen, O; Vik, A | 1 |
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Brunori, L; Fattorini, L; Giannoni, F; Iona, E; Orefici, G; Pardini, M | 1 |
Bohlin, L; Charnock, C; Gundersen, LL; Hedner, E; Larsson, R; Samuelsen, Ø; Tangen, LW; Vik, A | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Bitting, C; Gruppo, V; Johnson, CM; Lenaerts, AJ; Marietta, KS; Orme, IM; Woolhiser, L | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Basaraba, RJ; Brooks, EJ; Caraway, ML; Driver, ER; Hoff, DR; Lenaerts, AJ; Orme, IM; Peloquin, CA; Ryan, GJ | 1 |
Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chopra, S; Doppalapudi, RS; Franzblau, SG; Green, CE; Iyer, LV; Koolpe, GA; Madrid, PB; Matsuyama, KN; Riccio, ES; Ryan, KJ; Tambo-Ong, AA; Tran, TB; Wan, B | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Chaturvedi, V; Dasgupta, A; Gupta, AD; Jaiswal, S; Kashyap, VK; Khan, SR; Krishnan, MY; Lal, J; Roy, KK; Saxena, AK; Sharma, A; Sharma, SK; Singh, S; Sinha, S; Srivastava, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bloomer, WD; Kaiser, M; Papadopoulou, MV; Rosenzweig, HS | 1 |
Bloomer, WD; Papadopoulou, MV; Rosenzweig, HS | 1 |
Bonnet, M; Cooper, CB; Denny, WA; Franzblau, SG; Lee, HH; Thompson, AM; Wan, B; Wong, GS | 1 |
Chen, J; Ding, C; Doyle, T; Duncan, L; Ebright, RH; He, S; Lin, W; Liu, Y; Lynch, AS; Ma, Z; Molodtsov, V; Nguyen, P; Pulse, M; Robertson, GT; Wang, H; Weiss, WJ; Xu, X; Yuan, Y; Zhuang, Z | 1 |
Gugler, R | 1 |
Griffiths, WA | 1 |
Ho, SW | 1 |
Finegold, SM | 1 |
Guida, G; Minucci, D; Rabasso, A | 1 |
Bacon, AE; Fekety, R; Holloway, WJ; McGrath, S | 1 |
Arora, SK; Sehgal, S; Sinha, R | 1 |
Sinha, PK; Thakur, CP | 1 |
Laine, BM; Maier, KA; Mitten, JE; Stevens, DL | 1 |
Maier, KA; Mitten, JE; Stevens, DL | 1 |
Laine, BM; Mitten, JE; Stevens, DL | 1 |
Chong, H | 1 |
Drugeon, HB; Freland, C; Massoubre, B | 1 |
Azab, M; El-Missery, A; Khalil, N; Makhlouf, S; Makled, M; Rifaat, M | 1 |
Feingold, DS; Wagner, RF | 1 |
Pankey, GA; Valainis, GT | 1 |
Leigh, DA | 1 |
Bell, DR | 1 |
Lerner, PI | 1 |
Finegold, SM; Nastro, LJ | 1 |
Bailey, AR; Brunt, ME; James, DG; Walker, AN | 1 |
Everett, ED; Strausbaugh, LJ | 1 |
Berman, JD; Lee, LS | 1 |
Flenley, DC | 1 |
Amatnieks, YE; Ralph, ED | 1 |
Fu, KP; Kimble, EF; Konopka, EA; Lasinski, ER; Zoganas, HC | 1 |
Chaouat, A; Grunenberger, S; Ifoundza, TP; Kessler, R; Weitzenblum, E | 1 |
Byrd, RP; Fields, CL; Ossorio, MA; Roy, TM | 1 |
Hoshino, E; Iwaku, M; Kota, K; Kurihara-Ando, N; Sato, I; Sato, M; Uematsu, H | 1 |
Herbert, D; Kubendiran, G; Paramasivan, CN | 1 |
Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
Jiang, Q; Taylor, DE; Wang, G; Wilson, TJ | 1 |
Fujimura, S; Kato, S; Kawamura, T; Watanabe, A | 1 |
Akbar, DH; Al-Huzali, AM; Al-Shehri, HZ; Falatah, HI | 1 |
Inoue, M; Li, Q; Nagata, K; Park, AM; Sato, EF; Shimono, K; Tamura, T | 1 |
Artem'ev, MI; Baranovskiĭ, PM; Kiselev, VI; Obozova, TA; Smetanina, SE | 1 |
Elliott, S; Elliott, TS; Kowlessar, PI; Mitchell, RD; O'Connell, NH | 1 |
Bernard, P; Conscience, I; Le Berruyer, PY; Perceau, G | 1 |
Holmes, S; Lagrotteria, D; Lee, C; Smaill, F; Smieja, M | 1 |
Akrawi, H; Jones, G; Sparrow, OC; Vajramani, GV | 1 |
Kibadi, K | 1 |
Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
Alves, SH; Azevedo, MI; Botton, S; Cavalheiro, AS; Lovato, L; Santurio, JM; Spader, TB; Zanette, RA | 1 |
Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
Fattorini, L; Filippini, P; Iona, E; Neyrolles, O; Peyron, P; Piccaro, G | 1 |
Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D | 1 |
Milánkovits, M | 1 |
Drekonja, DM | 1 |
Behillil, S; Berche, P; Coignard, H; Consigny, PH; Fraitag, S; Guet-Revillet, H; Jais, JP; Join-Lambert, O; Jullien, V; Le Guern, AS; Leflèche, A; Lortholary, O; Nassif, A; Nassif, X; Poirée, S; Ribadeau-Dumas, F; Thèze, J | 1 |
Claxton, A; Erskine, K; Melendez, J | 1 |
Isaacs, J; Pullan, RD; Whelan-Johnson, S | 1 |
Jhobta, A; Kanga, A; Mokta, J; Negi, RS; Singh, DV; Verma, G; Verma, S | 1 |
Huh, KC; Jang, BI; Jung, Y; Kim, SH; Koo, HS; Lee, SW; Lee, YM; Moon, HS; Shin, JE; Yoon, SM | 1 |
Bettoli, V; Join-Lambert, O; Nassif, A | 1 |
Enninger, A; Ignatius, R; Raecke, O; Regnath, T | 1 |
Costa, S; Gonçalves, R; Soares, JB | 1 |
Caminero Luna, JA; Cerezo Lajas, A; de Miguel Díez, J; Rodríguez Guzmán, MDC | 1 |
Nielsen, SY; Nørskov-Lauritsen, N | 1 |
Alix, C; Bénéjat, L; Bessède, E; Charron, P; Ducournau, A; Lehours, P; Mégraud, F | 1 |
Goyal, P; Gupta, A; Kumar, P; Singh, M | 1 |
Abay, S; Akar, M; Aydın, F; Karakaya, E; Kayman, T | 1 |
Abouwarda, AM; Abu El-Wafa, WM; Faraag, AHI; Ismail, TA | 1 |
Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
Agay-Shay, K; Azrad, M; On, A; Paritski, M; Peretz, A; Rohana, H; Roshrosh, H; Vazana, D | 1 |
Chu, N; Gu, Y; Luo, H; Wang, Q; Xiao, Y; Yang, J; Zhang, J | 1 |
Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Yang, T | 1 |
7 review(s) available for metronidazole and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
Antibacterial therapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clindamycin; Drug Combinations; Erythromycin; Humans; Methicillin; Metronidazole; Nalidixic Acid; Penicillin Resistance; Penicillins; Rifampin; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Antimicrobial agents and the central nervous system.
Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Cephamycins; Chloramphenicol; Erythromycin; Humans; Infections; Lincomycin; Meningitis; Metronidazole; Penicillins; Polymyxins; Rifampin; Sulfonamides; Tetracyclines; Trimethoprim; Vancomycin | 1980 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
Delayed onset of pseudomembranous colitis after rifampin therapy.
Topics: Antibiotics, Antitubercular; Antidiarrheals; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; HIV Enteropathy; Humans; Male; Metronidazole; Middle Aged; Rifampin | 1997 |
Antibiotic Treatment of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin | 2016 |
2 trial(s) available for metronidazole and rifampin
Article | Year |
---|---|
Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar.
Topics: Antiprotozoal Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Leishmaniasis, Visceral; Male; Metronidazole; Random Allocation; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Rifampin | 2006 |
86 other study(ies) available for metronidazole and rifampin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
(+)-agelasine D: improved synthesis and evaluation of antibacterial and cytotoxic activities.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Diterpenes; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Mice; Microbial Sensitivity Tests; Molecular Structure; Porifera; Purines; Stereoisomerism; Tumor Cells, Cultured | 2006 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Drug Combinations; Metronidazole; Mycobacterium tuberculosis; Rifampin | 2007 |
Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridones; Quinolones; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Metronidazole lacks antibacterial activity in guinea pigs infected with Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Female; Guinea Pigs; Isoniazid; Lung; Metronidazole; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Spleen; Tuberculosis, Pulmonary | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Female; Isomerism; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxides; Quinoxalines; Rats; Tirapazamine; Triazines; Tuberculosis; Vero Cells | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
Topics: Adenosine Triphosphate; Animals; Antitubercular Agents; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Proton-Translocating ATPases; Quinolines; Rats, Sprague-Dawley; Sulfonamides; Tuberculosis | 2015 |
The antitrypanosomal and antitubercular activity of some nitro(triazole/imidazole)-based aromatic amines.
Topics: Amines; Antitubercular Agents; Dose-Response Relationship, Drug; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2017 |
The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Topics: Animals; Antitubercular Agents; Cell Line; Chlorocebus aethiops; Dose-Response Relationship, Drug; Humans; Imidazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitro Compounds; Structure-Activity Relationship; Triazoles | 2017 |
Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid.
Topics: | 2017 |
Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Topics: Anaerobiosis; DNA-Directed RNA Polymerases; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Rifamycins | 2022 |
[Drug interactions in therapy using coumarin derivatives].
Topics: Allopurinol; Anti-Inflammatory Agents; Barbiturates; Biological Availability; Cholestyramine Resin; Coumarins; Drug Interactions; Humans; Metronidazole; Phenylbutazone; Rifampin; Sulfonamides; Tolbutamide | 1979 |
Use of metronidazole in cutaneous leishmaniasis.
Topics: Humans; Leishmaniasis; Metronidazole; Rifampin | 1976 |
Standardization of antimicrobial disc susceptibility test for anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; Carbenicillin; Cephalothin; Chloramphenicol; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracyclines | 1976 |
Antimicrobial therapy of anaerobic infections.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Bacteria; Humans; Lincomycin; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Thiamphenicol; Vancomycin | 1975 |
[Dysplasia and carcinoma in situ of the uterine cervix. Outcome of several cases].
Topics: Adult; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Metronidazole; Nystatin; Precancerous Conditions; Rifampin; Tetracycline; Uterine Cervical Neoplasms | 1975 |
In vitro synergy studies with Clostridium difficile.
Topics: Bacitracin; Clostridioides difficile; Drug Combinations; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1991 |
Use of in vitro method to assess different brands of anti-leishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; In Vitro Techniques; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Metronidazole; Mice; Mice, Inbred BALB C; Rifampin | 1991 |
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridium perfringens; Female; Gas Gangrene; Male; Metronidazole; Mice; Penicillin G; Rifampin; Tetracycline | 1987 |
Effect of antibiotics on toxin production and viability of Clostridium perfringens.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Calcium-Binding Proteins; Cefoxitin; Chloramphenicol; Clindamycin; Clostridium perfringens; Kinetics; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Rifampin; Tetracycline; Type C Phospholipases | 1987 |
Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.
Topics: Animals; Clindamycin; Clostridium perfringens; Drug Therapy, Combination; Female; Gas Gangrene; Male; Metronidazole; Mice; Microbial Sensitivity Tests; Penicillin G; Rifampin | 1987 |
[Susceptibility of Campylobacter pyloridis to antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Campylobacter; Chloramphenicol; Colistin; Lactams; Metronidazole; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Rifampin | 1987 |
Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis.
Topics: Adult; B-Lymphocytes; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Immunoglobulin M; Leishmaniasis; Levamisole; Male; Metronidazole; Middle Aged; Rifampin; T-Lymphocytes | 1987 |
Choosing antimicrobials. Factors to consider, available agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Clindamycin; Drug Interactions; Drug Therapy, Combination; Erythromycin; Humans; Kidney Failure, Chronic; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Tetracycline; Tissue Distribution; Vancomycin | 1985 |
Letter: Bacteroides infections.
Topics: Bacteroides; Bacteroides Infections; Clindamycin; Culture Media; Drug Evaluation; Drug Resistance, Microbial; Drug Synergism; Humans; Intestinal Diseases; Lincomycin; Metronidazole; Rifampin; Surgical Wound Infection; Tetracycline | 1973 |
Treatment of venereal diseases.
Topics: Chancroid; Drug Combinations; Erythromycin; Female; Gonorrhea; Granuloma Inguinale; Humans; Injections, Intramuscular; Kanamycin; Lymphogranuloma Venereum; Male; Metronidazole; Penicillin Resistance; Penicillins; Rifampin; Sexually Transmitted Diseases; Streptomycin; Sulfamethoxazole; Sulfonamides; Syphilis; Tetracycline; Trimethoprim; Urethritis | 1973 |
Antimicrobial considerations in anaerobic infections.
Topics: Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium Infections; Erythromycin; Fusobacterium; Humans; Lincomycin; Metronidazole; Microbial Sensitivity Tests; Oxygen; Penicillins; Rifampin; Streptococcal Infections; Tetracycline; Treponemal Infections; Vancomycin; Veillonella | 1974 |
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides; Clindamycin; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Vancomycin | 1972 |
Fresh drugs for old problems.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Azathioprine; Cephalosporins; Humans; Liver Abscess, Amebic; Metronidazole; Purpura, Thrombocytopenic; Respiratory Tract Infections; Rifampin; Sarcoidosis; Urinary Tract Infections | 1971 |
Activity of oral drugs against Leishmania tropica in human macrophages in vitro.
Topics: Antiprotozoal Agents; Cells, Cultured; Drug Interactions; Humans; Isoniazid; Ketoconazole; Leishmania; Macrophages; Metronidazole; Nitrofurans; Phenothiazines; Quinacrine; Rifampin; Sulfamethoxazole; Trimethoprim | 1983 |
Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Clindamycin; Drug Synergism; Erythromycin; Humans; Metronidazole; Nalidixic Acid; Penicillin Resistance; Rifampin; Spectinomycin; Ticarcillin | 1980 |
Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
Topics: Abscess; Administration, Oral; Animals; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Female; Injections, Subcutaneous; Kinetics; Metronidazole; Mice; Mice, Inbred Strains; Peritoneal Diseases; Rifampin | 1984 |
[Diffuse nodular dissemination of thoracic actinomycosis].
Topics: Actinomycosis; Adult; Drug Therapy, Combination; Fusidic Acid; Humans; Male; Metronidazole; Radiography; Rifampin; Tetracycline Resistance; Tetracyclines; Thoracic Diseases; Time Factors | 1994 |
In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacteria, Anaerobic; Ciprofloxacin; Dental Caries; Dental Pulp Cavity; Dentin; Drug Combinations; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Periapical Diseases; Pulpitis; Rifampin | 1996 |
Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.
Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Metronidazole; Mice; Mice, Inbred BALB C; Rifampin; Tuberculosis | 1998 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Transformation, Bacterial | 2001 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2002 |
A case of rifampicin induced pseudomembraneous colitis.
Topics: Abdominal Pain; Adult; Biopsy, Needle; Colonoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Immunohistochemistry; Metronidazole; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
Oxygen tension regulates reactive oxygen generation and mutation of Helicobacter pylori.
Topics: Aerobiosis; Anaerobiosis; Bacterial Proteins; Ciprofloxacin; Cytochromes c; DNA; Drug Resistance; Guanine; Helicobacter pylori; Metronidazole; Mutation; Oxidative Stress; Oxygen; Reactive Oxygen Species; Rifampin; Superoxide Dismutase; Urease | 2004 |
[Correlation between the expression of Rv3286c, Rv2626c, Rv2031c, AND Rv3133c and the tolerance of Mycobacterium bovis BCG to rifampicin and metronidazole in different physiological conditions].
Topics: Animals; Antibiotics, Antitubercular; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Genes, Bacterial; In Vitro Techniques; Metronidazole; Mycobacterium bovis; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger | 2005 |
Management of patients with Streptococcus milleri brain abscesses.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Infective Agents; Brain Abscess; Causality; Cefotaxime; Cohort Studies; Drainage; Female; Glasgow Outcome Scale; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Rifampin; Risk Factors; Streptococcal Infections; Streptococcus milleri Group; Time Factors; Treatment Outcome | 2006 |
[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia].
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breast Diseases; Cellulitis; Clavulanic Acid; Colonic Polyps; Colonoscopy; Drug Therapy, Combination; Female; Humans; Metronidazole; Rifampin; Sepsis; Sigmoid Neoplasms; Streptococcal Infections; Streptococcus agalactiae; Time Factors; Treatment Outcome | 2006 |
Primary ventriculitis caused by Streptococcus intermedius.
Topics: Anti-Infective Agents; Cefotaxime; Cerebral Ventricles; Encephalitis; Endoscopy; Glasgow Coma Scale; Humans; Hydrocephalus; Male; Metronidazole; Middle Aged; Rifampin; Streptococcal Infections; Streptococcus intermedius; Tomography, X-Ray Computed | 2007 |
[Mycobacterium ulcerans infection treated by Rifater, pyrazynamide, Myambutol, and surgery: a case report with a 6-year follow-up].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Chloramines; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Mastectomy; Metronidazole; Mycobacterium ulcerans; Nitrofurantoin; Pleurisy; Prednisolone; Pyrazinamide; Recurrence; Rifampin; Skin Transplantation | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum.
Topics: Amphotericin B; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Ibuprofen; Indoles; Metronidazole; Microbial Sensitivity Tests; Naphthalenes; Pythium; Rifampin; Terbinafine | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Activity of drug combinations against dormant Mycobacterium tuberculosis.
Topics: 3T3 Cells; Adipocytes; Amikacin; Animals; Antitubercular Agents; Aza Compounds; Capreomycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Latent Tuberculosis; Metronidazole; Mice; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin | 2010 |
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin | 2010 |
[Combined local and vaginal therapy in Buruli ulcer].
Topics: Adolescent; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Amikacin; Anti-Infective Agents; Buruli Ulcer; Child; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Humans; Metronidazole; Mycobacterium ulcerans; Osteomyelitis; Rifampin; Streptomycin | 2010 |
Rifampin plus metronidazole for Clostridium difficile infection.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Rifampin | 2010 |
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Metronidazole; Middle Aged; Moxifloxacin; Prognosis; Quinolines; Recurrence; Remission Induction; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2011 |
MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Cesarean Section; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Staphylococcal Infections; Teicoplanin; Trimethoprim; Wound Infection | 2012 |
Sacro-iliac osteomyelitis in a 13 year old boy following perforated appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ascitic Fluid; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Humans; Laparotomy; Magnetic Resonance Imaging; Male; Metronidazole; Osteomyelitis; Rifampin; Rupture, Spontaneous; Sacroiliitis | 2013 |
Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.
Topics: Antiprotozoal Agents; Antitubercular Agents; Bronchoalveolar Lavage; Ceftriaxone; Dose-Response Relationship, Drug; Humans; India; Isoniazid; Lung Diseases, Parasitic; Male; Metronidazole; Middle Aged; Mycobacterium tuberculosis; Parabasalidea; Rifampin; Trophozoites; Tuberculosis, Pulmonary | 2015 |
Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotics, Antitubercular; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Incidence; Male; Metronidazole; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany.
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Prevalence; Retrospective Studies; Rifampin | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Antituberculosis Treatment in a Patient with Celiac Disease.
Topics: Aged; Antitubercular Agents; Celiac Disease; Diarrhea; Diet, Gluten-Free; Drug Compounding; Drug Substitution; Drug Therapy, Combination; Ethambutol; Glutens; Hemoptysis; Humans; Isoniazid; Male; Metronidazole; Moxifloxacin; Pyrazinamide; Rifampin; Smoking; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2018 |
Multispacer sequence typing of Coxiella burnetii DNA from removed prosthetic heart valve material discloses first human case of infective endocarditis caused by MST_18.
Topics: Abscess; Aged; Aortic Valve; Coxiella burnetii; Denmark; DNA, Bacterial; Doxycycline; Echinocandins; Endocarditis, Bacterial; Fatal Outcome; Gentamicins; Heart Valve Prosthesis; Humans; Male; Meropenem; Metronidazole; Multilocus Sequence Typing; Rifampin; RNA, Ribosomal, 16S; Vancomycin | 2019 |
Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin | 2021 |
Chol-Dex nanomicelles: Synthesis, characterization and evaluation as efficient drug carriers for colon targeting.
Topics: Cell Survival; Cholesterol; Colon; Dextrans; Drug Carriers; Drug Delivery Systems; HEK293 Cells; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Metronidazole; Micelles; Molecular Structure; Nanostructures; Rifampin | 2021 |
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin; Turkey; Young Adult | 2021 |
Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Fosfomycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Rifampin | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2022 |
Antimicrobial Resistance of Helicobacter Pylori Among Low-resource Chinese Minorities.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; East Asian People; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Moxifloxacin; Rifampin | 2023 |
Roles of Lipopolysaccharide Glycosyltransferases in Maintenance of
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Wall; Clarithromycin; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Metronidazole; Microbial Sensitivity Tests; Permeability; Rifampin | 2023 |